Drugs / DYV700
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04130204 | Feb 2020 → May 2021 | gout | Dyve Biosciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DYV700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04130204 ↗ |
| Route | Topical | “DYV700 is applied topically” NCT04130204 ↗ |